Edap Tms S.A. logo

Edap Tms S.A. (EDAP)

Market Closed
2 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
4. 7550
-0.025
-0.52%
$
153.68M Market Cap
- P/E Ratio
- Div Yield
28,865 Volume
-0.38 Eps
$ 4.78
Previous Close
Investors:
Add Transaction
Day Range
4.5001 4.8
Year Range
1.21 5.05
Want to track EDAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EDAP closed yesterday lower at $4.75, a decrease of -0.52% from Monday's close, completing a monthly increase of 41.94% or $1.4. Over the past 12 months, EDAP stock gained 40.27%.
EDAP is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

EDAP Chart

People also search for

Acimmune SA
$ 2.39
-1.24%
Zentalis Pharmaceuticals, Inc.
$ 3.72
-5.82%
Fate Therapeutics Inc.
$ 2.22
-13.62%
ALT
Altimmune, Inc.
$ 2.87
-1.03%
Entrada Therapeutics Inc.
$ 6.58
-0.9%
Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion

Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion

Edap Tms NASDAQ: EDAP used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play robotic focal therapy company,” with management emphasizing the company's Focal One robotic high-intensity focused ultrasound, or HIFU, platform for prostate cancer and future indications.

Marketbeat | 2 days ago
EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago
EDAP TMS S.A. (EDAP) Q3 2025 Earnings Call Transcript

EDAP TMS S.A. (EDAP) Q3 2025 Earnings Call Transcript

EDAP TMS S.A. ( EDAP ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Ryan Rhodes - CEO & Director Ken Mobeck - Chief Financial Officer Conference Call Participants John Fraunces - Lifesci Advisors, LLC Charles Wallace - H.C.

Seekingalpha | 6 months ago

Edap Tms S.A. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Robert Bruce
Robert Bruce Robert Jeffrey Bruce is VP/Secretary at Bruce & Co Inc.
438,652 $850,968.52 $2.08M $1.23M 145.11%

Edap Tms S.A. (EDAP) FAQ

What is the stock price today?

The current price is $4.7550.

On which exchange is it traded?

Edap Tms S.A. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is EDAP.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 153.68M.

Has Edap Tms S.A. ever had a stock split?

No, there has never been a stock split.

Edap Tms S.A. Profile

Health Care Technology Industry
Healthcare Sector
Ryan Rhodes CEO
NASDAQ (NMS) Exchange
268311107 CUSIP
FR Country
310 Employees
- Last Dividend
- Last Split
31 Jul 1997 IPO Date

Overview

EDAP TMS S.A. is an established company focusing on the development, production, marketing, distribution, and maintenance of minimally invasive medical devices aimed at the treatment of urological diseases. The company has a global presence, with operations spanning Asia, France, the United States, and other international markets. Structurally, EDAP TMS S.A. operates through three main segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). These segments represent the company's commitment to offering advanced, minimally invasive solutions for urological care. Founded in 1979, the company has its headquarters in Lyon, France, and caters to a diverse client base that includes hospitals, urology clinics, and research institutions. The firm leverages both direct marketing and sales through third-party distributors and agents to ensure its cutting-edge medical devices are accessible globally.

Products and Services

  • High Intensity Focused Ultrasound (HIFU):

    EDAP TMS S.A.'s HIFU segment focuses on the development, manufacturing, and marketing of medical devices that utilize high-intensity focused ultrasound technology. This technology facilitates minimally invasive treatment options for urological and other clinical indications. Within this segment, notable products include Ablatherm, a robotic HIFU device designed for the ultrasound-guided treatment of organ-confined prostate cancer, and Focal One, a robotic HIFU device primarily dedicated to the focal therapy of prostate cancer. The segment not only offers these advanced therapeutic devices but also provides disposables, leasing, treatment-related services, and maintenance services.

  • Extracorporeal ShockWave Lithotripsy (ESWL):

    This division of EDAP TMS focuses on the manufacturing, marketing, and servicing of lithotripters used for the treatment of urinary tract stones through ESWL technology. The Sonolith i-move stands out as a key product in this category, offering an advanced extracorporeal shockwave lithotripter solution. Additionally, the company supplies disposable parts for lithotripters and electrodes, ensuring comprehensive support and maintenance for the longevity and efficiency of the devices.

  • Distribution Services (DIST):

    The DIST segment operates to market, distribute, and service a range of medical products, including lasers and micro-ultrasound systems from third parties. This division extends the company's reach by offering leasing options for devices, as well as selling disposables and spare parts. It further supports its product offerings through maintenance services, thereby ensuring that clients receive end-to-end solutions for their medical device needs. Through this segment, EDAP TMS S.A. leverages its extensive sales organization and service platform to deliver quality products and excellent service to its customers.

Contact Information

Address: Parc d’Activites la Poudrette-Lamartine
Phone: 33 4 72 15 31 50